// App-Quantinova.ai

TCT-207 : Extended validation of a decision tool (DAPT score) in patients randomized to 6 or 12 months dual antiplatelet therapy after percutaneous coronary intervention with predominantly second-generation drug-eluting stents

Researchers

Presenter

  • Yukinori Harada

Principal Investigators

  • Raphaela Lohaus

  • Katharina Mayer

  • Roberto Emmer

  • Jonathan Michel

  • Roisin Colleran

  • Daniele Giacoppo

  • Jens Wiebe

  • Robert Byrne

  • Adnan Kastrati

  • Stefanie Schulz-Schupke

Medical Centers

  • Deutsches Herzzentrum Munchen, Technische Universitat Munchen, Munich, Germany

  • Deutsches Herzzentrum Munchen, Munich, Germany

  • Deutsches Herzzentrum Munchen, Munich, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved